Improvement in Standard of Care in Atopic Dermatitis

Author(s):

Linda Stein Gold, MD,Alexandra K. Golant, MD

Panelists discuss how the standard of care in atopic dermatitis (AD) has evolved with recent advances in treatment, highlighting the use of assessment tools and scoring systems in clinical practice, and compare real-world outcomes with those seen in clinical trials for AD treatments.

EP: 1.Heterogenous Presentation Of Atopic Dermatitis

EP: 2.Use of Biopsy and Diagnosing New-Onset AD

EP: 3.Treatment Options in Atopic Dermatitis

Now Viewing

EP: 4.Improvement in Standard of Care in Atopic Dermatitis

EP: 5.Improvement in Patients’ Qualify of Life with Atopic Dermatitis Treatments

EP: 6.Guidance for Moving to Advanced Systemic Therapy and Biologic Agents

EP: 7.IL-13–Targeting Agents in Atopic dermatitis

EP: 8.Efficacy Data With IL-13 Targeting Agents in Atopic Dermatitis

EP: 9.Less Frequent Administration of Lebrikizumab for Atopic Dermatitis

EP: 10.Switching or Staying Within the Treatment Class

EP: 11.Use of Combination Therapy in Atopic Dermatitis

EP: 12.Safety Data With Biologics in Atopic Dermatitis

Video content above is prompted by the following:

How has the standard of care in AD changed with recent advances?
What assessment tools and scoring systems do you use in your practice?
When looking at clinical outcomes, are you seeing results with AD treatments in your practice that are similar to what has been reported in clinical trials?